VASP and esophageal squamous cell carcinoma: The authors found that LAMP3-deficient ESCC cells had drastically reduced metastatic traits (invasive and metastatic capability) compared to non-deficient ESCC cells via activation of the cAMP-dependent protein kinase A (PKA)-mediated VASP phosphorylation pathway [152].